36. 下列單胺氧化酶（MAO）抑制劑中，何者較適合用於巴金森氏症？
(A) Moclobemide
(B) Phenelzine
(C) Selegiline
(D) Tranylcypromine

答案：登入後查看
統計： A(1), B(3), C(32), D(0), E(0) #510111

詳解 (共 1 筆)

#820335
Selegiline is a drug used for the treatment of early-stage Parkinson's disease, depression and dementia. In normal clinical doses it is a selective irreversible MAO-B inhibitor. However, in larger doses it loses its specificity and also inhibits MAO-A. 
0
0